
NDZ plans to acquire a 75.1521% stake in Charles Schwab to expand its business reach

I'm PortAI, I can summarize articles.
NDZ plans to acquire 75.1521% of the equity of Charles River Laboratories through the issuance of shares and cash payments to expand its business scope. 50% of the transaction price will be paid in shares, and 50% will be paid in cash, with an issuance price of RMB 8.44 per share. This transaction will enhance the company's market share in East China, North China, South China, and Southwest China, promoting the implementation of its national strategy
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

